Key result
Enoxaparin reduces inferior vena cava thrombus size ~61% in a mouse thrombosis model.
Why the study?
A rodent model that generates consistent venous thrombi in the presence of continuous blood flow to evaluate therapeutic agents for DVT was not available.
Effect estimate: 61% reduction
The electrolytic inferior vena cava model in mice generates consistent venous thrombi with continuous blood flow, providing a reliable preclinical model for deep venous thrombosis research.
No takes yet. Share an insight, caveat, or question.
Electrolytic IVC model yields consistent murine DVT thrombi under flow; leaves open translation to human therapeutic testing.
Hawley et al. (2010) studied Deep venous thrombosis. Electrolytic inferior vena cava model (EIM) and Enoxaparin vs. Wild-type mice / Control was evaluated on Thrombus formation and size (61% reduction). An electrolytic inferior vena cava model consistently promoted thrombus formation in mice, and enoxaparin significantly reduced thrombus size by 61%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: